← Eichor
Condition: Biomarker Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Biomarker

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Personalised Immunotherapy Platform
Phase N/A · 3 location(s) · Melanoma Institute Australia · NCT06536257PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07717281Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Phase N/A · 1 location(s) · Medical College of Wisconsin · NCT00710112Cardiac Structure and Function in MPS
Phase N/A · 3 location(s) · Children's Hospital of Orange County · NCT07361536A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fractio
Phase 1 · 21 location(s) · Vasa Therapeutics · NCT07219511Leg Ischaemia Management Collaboration
Phase N/A · 1 location(s) · University of Leicester · NCT04027244Clinical Research in ALS Study
Phase N/A · 1 location(s) · University of Miami · NCT00136500Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery
NA · 1 location(s) · Poznan University of Medical Sciences · NCT07474909Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT06828263Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05443412Study of Natural Course Progression of Diabetic Retinopathy
Phase N/A · 1 location(s) · Jie Li · NCT06269419CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Phase N/A · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT05828628Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Phase N/A · 1 location(s) · University of Aarhus · NCT05763511Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline an
Phase N/A · 3 location(s) · Istituto Nazionale di Ricovero e Cura per Anziani · NCT07435467A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Present
NA · 1 location(s) · Eli Lilly and Company · NCT07140744Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibi
Phase N/A · 6 location(s) · Shantou University Medical College · NCT07357636Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
Phase N/A · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06574373Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR
Phase N/A · 1 location(s) · Instituto de Investigacion Sanitaria La Fe · NCT06866769Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
NA · 2 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05765110Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Phase 2 · 6 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06745882IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients
Phase N/A · 1 location(s) · Ezgi Günaydın · NCT07460141Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT07407166Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Phase N/A · 23 location(s) · Alexion Pharmaceuticals, Inc. · NCT06967480Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolesce
NA · 2 location(s) · University of Alabama at Birmingham · NCT05437588Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Local
NA · 1 location(s) · University of Zurich · NCT07042256Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients
Phase N/A · 1 location(s) · Grigore T. Popa University of Medicine and Pharmacy · NCT07237451Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483Heat Shock Protein 47 in Thrombosis
Phase N/A · 2 location(s) · University of Aarhus · NCT06731673
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.